CONMED CNMD Stock options excluded as their inclusion would be anti-dilutive (in shares)
Stock options excluded as their inclusion would be anti-dilutive (in shares) at other companies
Other financials
Where this comes from
Reported directly by CONMED in its filing.
Tagged under the XBRL concept us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount.
The official record: CONMED’s 10-Q, filed April 30, 2026, on SEC EDGAR. View the filing →
Ask your AI about CONMED's stock options excluded as their inclusion would be anti-dilutive (in shares).
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is CONMED's stock options excluded as their inclusion would be anti-dilutive (in shares)?
- CONMED (CNMD) reported stock options excluded as their inclusion would be anti-dilutive (in shares) of 4.3M in Q1 2026.
- How has CONMED's stock options excluded as their inclusion would be anti-dilutive (in shares) changed year-over-year?
- CONMED's stock options excluded as their inclusion would be anti-dilutive (in shares) increased by 26.5% year-over-year, from 3.4M to 4.3M.
- What is the long-term trend for CONMED's stock options excluded as their inclusion would be anti-dilutive (in shares)?
- Over 4 years (2021 to 2025), CONMED's stock options excluded as their inclusion would be anti-dilutive (in shares) has grown at a 60.9% compound annual growth rate (CAGR), from 2.3M to 15.4M.
- What does stock options excluded as their inclusion would be anti-dilutive (in shares) mean?
- The count of stock options or other convertible securities that are excluded from the diluted earnings per share calculation because their inclusion would increase earnings per share. These instruments are currently 'out-of-the-money' and do not pose an immediate dilution risk.